Axonics® to Present at the SVB Leerink Global Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

IRVINE, Calif.–(BUSINESS WIRE)–Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced that Chief Executive Officer Raymond W. Cohen is scheduled for a fireside chat at the 9th Annual SVB Leerink Global Healthcare Conference, Tuesday, February 25, at 3:30pm ET in New York City, and will be available for meetings with institutional investors.

To access the live webcast of the fireside chat, please visit the Events & Presentations page of the Investor Relations section of the Company’s website at ir.axonics.com. A replay of the webcast will be available shortly after the conclusion of the fireside chat and will be archived on the Company’s website for 90 days.

About Axonics Modulation Technologies, Inc.

Axonics, based in Irvine, Calif., has developed and is commercializing novel implantable SNM devices for patients with urinary and bowel dysfunction. These conditions are caused by a miscommunication between the bladder and the brain and significantly impacts quality of life. Overactive bladder affects an estimated 87 million adults in the U.S. and Europe. Another estimated 40 million adults are reported to suffer from fecal incontinence/accidental bowel leakage. SNM therapy has been employed to reduce symptoms and restore pelvic floor function for the past two decades. Reimbursement coverage is well established in the U.S. and Europe. The Axonics System is the first rechargeable SNM system approved for sale in the world, and the first to gain full-body MRI conditional labeling. For more information, visit the Company’s website at www.axonics.com.

Contacts

Axonics’ Contact

Axonics Modulation Technologies, Inc.

Dan Dearen, +1-949-396-6320

President & Chief Financial Officer

ir@axonics.com

Investor & Media Contact
W2Opure

Matt Clawson, +1-949-370-8500

mclawson@w2ogroup.com

Staff

Recent Posts

Freeze Drying Equipment Market to Surge from USD 4.9 Billion to USD 8.4 Billion by 2032 – Meticulous Research®

Lyophilization Process Innovation, Food Preservation Demand, and Pharmaceutical Industry Expansion Drive 7.9% CAGR Growth Across…

18 minutes ago

Texas Centers for Infectious Disease Associates Notifies Individuals of Data Security Incident

FORT WORTH, Texas, June 27, 2025 /PRNewswire/ -- Texas Centers for Infectious Disease Associates ("TCIDA")…

18 minutes ago

Dogtopia’s Redesigned Wellness App Drives Convenience and Engagement for Parents, Activity and Exercise Tracking for Dogs

PHOENIX, June 27, 2025 /PRNewswire/ -- Dogtopia, the nation's largest and fastest-growing pet wellness franchise, has…

6 hours ago

Patient Advocate Foundation Praises SCOTUS Decision Upholding Preventative Care Provision in Affordable Care Act

HAMPTON, Va., June 27, 2025 /PRNewswire/ -- Patient Advocate Foundation (PAF), a national non-profit charity…

6 hours ago

Pinnacle Fertility Appoints Dr. Richard Scott to Board of Directors, Signaling Leap Forward in Scientific and Strategic Excellence

SCOTTSDALE, Ariz., June 27, 2025 /PRNewswire/ -- Pinnacle Fertility proudly announces the appointment of Dr.…

6 hours ago

Croom Lawrence Joins Hemostemix with Revenue Share Agreement and VesCell.Health Launch

Calgary, Alberta--(Newsfile Corp. - June 27, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF), a…

12 hours ago